Lucid Diagnostics Inc. Common Stock

LUCDNASDAQUSD
1.00 USD
0.00 (0.20%)🟢LIVE (AS OF 12:08 PM EDT)
🟢Market: OPEN

Lucid Diagnostics Inc. Common Stock (LUCD) trades at $1.00 per share. There is a divergence between signals — technical indicators rate "Strong Buy" but underlying fundamentals lean "Sell". Key drivers include a concerning Altman Z-Score in the distress zone, negative Return on Equity and a bearish Death Cross on the long-term moving averages. Furthermore, LUCD is currently richly valued, trading at a premium to sector peers across key valuation metrics.

Technical & fundamental data as of Aug 24, 2026.

Open?$1.00
High?$1.04
Low?$0.99
Prev. Close?$1.00
Volume?640.6K
Avg. Volume?1.3M
VWAP?$1.01
Rel. Volume?0.49x
Bid / Ask
Bid?$0.85 × 100
Ask?$1.14 × 100
Spread?$0.29
Midpoint?$1.00
Valuation & Ratios
Market Cap?190.9M
Shares Out?203.2M
Float?156.5M
Float %?77.1%
P/E Ratio?N/A
P/B Ratio?17.47
EPS?-$0.34
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.
Employees
82
Market Cap
184.1M
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Listed
2021-10-14
Address
360 MADISON AVENUE
NEW YORK, NY 10017
Phone: 212 949 4319
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bullish(+1/3)
Medium-Term (Wave)? Bullish(+2/3)
Short-Term (Ripple)? Bullish(+3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
23
Z-Score?
0
Momentum?
27
Short Sent.?
49
Piotroski F-Score?3/9Weak
Altman Z-Score?-11.03Distress
Confidence?58%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?7.75%Elevated
Short Interest?12.1M
Days to Cover?8.3
Free Float156.5M
Avg Daily Volume1.5M
Settlement Date2026-07-31
Financial Health
Current Ratio?1.33Adequate
Quick Ratio?1.31Adequate
Cash Ratio?1.21Strong
Debt/Equity?2.15High
ValuationRICHLY VALUEDvs 1 peers + S&P 500
Score
50/100
P/E?
N/A
P/B?
Peers
100
S&P
9
17.47HIGH
P/S?
Peers
100
S&P
3
35.07HIGH
P/FCF?
N/A
EV/EBITDA?
S&P
97
-3.6CHEAP
EV/Sales?
Peers
100
S&P
3
33.25HIGH
Returns & Efficiency
ROE?
S&P
3
-594.9%WEAK
ROA?
S&P
3
-166.9%WEAK
Cash Flow & Enterprise
FCF?$-47184000
Enterprise Value?$181.0M
Fundamentals ratios updated end of day